Mergers & Acquisitions Mergers & Acquisitions

Sigma-Aldrich gets new EU charges over false information in merger review (update*)

By Lewis Crofts
  • 01 Jul 2020 06:43
  • 01 Jul 2020 07:47
German biotech company Sigma-Aldrich is the target of additional charges over alleged false information submitted to EU officials during a merger deal involving Merck KGaA.

The European Commission said today it had issued a supplementary Statement of Objections, replacing a 2017 charge sheet to focus just on Sigma (see here).

Merck won EU approval

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News